BakoDx Begins Testing Novel Coronavirus Samples


ATLANTA — Bako Diagnostics has expanded its molecular test portfolio to meet the U.S. need for the novel coronavirus testing, with results completed in 24 hours. The BakoDx SARS-CoV-2 RNA (COVID-19) test meets Centers for Disease Control and Prevention guidelines and will be offered under the U.S. Food and Drug Administration’s Emergency Use Authorization. The diagnostic laboratory, based in Alpharetta, Ga., began molecular testing for COVID-19 on April 6. BakoDx is able to perform more than 2,000 tests per day, with plans to increase that capacity. “Our development team has been working diligently to make COVID-19 testing more widely available [...]